DataM Intelligence | competitive Intelligence Spinal Muscular Atrophy treatment is evolving fast, with gene therapy, oral drugs, and next-g ...

Newborn with SMA gene mutation receives presymptomatic treatment at SAT Hospital, a rare step in managing rare diseases.

Spinal cord lesions are more commonly seen in progressive forms of multiple sclerosis, and they can result in an increased risk of disability. In relapsing-remitting MS, which 80 to 85 percent of ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Anna Landre, a college student who lives with spinal muscular atrophy, found herself fighting another battle when her insurer informed her they were reducing the number of hours they would cover ...

With such severe disability, contractures and muscle atrophy may be so far advanced that functional improvement is unlikely. However, we also found no evidence that the use of spinal cord ...

By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood ...

Annji Pharmaceutical Co. Ltd.’s rosolutamide (AJ-201, JM-17) achieved positive results in a phase I/II trial in adults with spinal and bulbar muscular atrophy, also known as Kennedy’s disease.

Physical examination findings correspond to the location of the tumor, degree of cord impingement, and duration of involvement. [3] The APN should palpate the entire spine to determine whether ...

Intracortical microstimulation of the somatosensory cortex evokes tactile sensations, but those of individual electrodes are insufficient for functional tasks. We show that stimulating multiple ...

This week, the US Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) approved the global clinical trial to treat spinal cord injury (SCI), which is ...